Cover Image

Varying presentations of immune checkpoint inhibitor-associated myocarditis: A case report of the clinical characteristics and outcomes of three patients

Saved in:

Bibliographic Details
Main Authors:	Brandon Fox (Author), Floor Backes (Author)
Format:	Book
Published:	Elsevier, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug therapy for myocarditis induced by immune checkpoint inhibitors
by: Yihao Wu, et al.
Published: (2023)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
by: Zou W, et al.
Published: (2021)

A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis
by: Solveig A. van der Vegt, et al.
Published: (2022)

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
by: Yanna Lei, et al.
Published: (2022)

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
by: Stefanovic F, et al.
Published: (2022)

Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature
by: Yuki Nakagomi, et al.
Published: (2022)

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis
by: Yudai Tamura, et al.
Published: (2023)

Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
by: Cong Wang, et al.
Published: (2021)

Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes
by: Abrahim Abduelmula, BScN, et al.
Published: (2022)

Immune checkpoint inhibitor-induced cholangitis-a three-case series
by: Simon Gray, et al.
Published: (2024)

A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors
by: Liu JC, et al.
Published: (2023)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
by: Jii Bum Lee, et al.
Published: (2021)

Immune Checkpoint Inhibitors New Insights and Recent Progress
Published: (2023)

The gut microbiota and immune checkpoint inhibitors
by: Audrey Humphries, et al.
Published: (2018)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020)

Immune Checkpoint Inhibitors and Lupus Erythematosus
by: Hans Vitzthum von Eckstaedt, et al.
Published: (2024)

Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
by: Sara Colomer-Lahiguera, et al.
Published: (2020)

Varied presentations of cutaneous rhinosporidiosis: A report of three cases
by: Thurakkal Salim, et al.
Published: (2016)

An analysis report on the application of immune checkpoint inhibitors after liver transplantation
by: Man Xie, et al.
Published: (2022)

Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway
by: Zhang H, et al.
Published: (2022)

Skin Manifestation Induced by Immune Checkpoint Inhibitors
by: Yamamoto T
Published: (2022)

Immune Checkpoint Inhibitors in Melanoma: Review and Update
by: Eugénia Matos Pires, et al.
Published: (2018)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
by: Xi Chen, et al.
Published: (2022)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
by: Ji Won Han, et al.
Published: (2021)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
by: Diederick J. van Doorn, et al.
Published: (2020)

Hepatobiliary complications of immune checkpoint inhibitors in cancer
by: Donna Zhuang, et al.
Published: (2024)

Immune checkpoint inhibitor-associated sarcoidosis reaction
by: Parisa Keshtgar, et al.
Published: (2023)

Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
by: Yusuke Nagata, et al.
Published: (2022)

Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases
by: Sonja Braasch, et al.
Published: (2022)

The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors
by: Lilong Zhang, et al.
Published: (2022)

Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy
by: Lilong Zhang, et al.
Published: (2022)

Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020)

Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
by: Giulio Metro, et al.
Published: (2021)

Mechanisms of immune checkpoint inhibitor-mediated liver injury
by: Layla Shojaie, et al.
Published: (2021)

Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
by: Pan Shen, et al.
Published: (2021)

Efficacy of immune checkpoint inhibitors in different types of melanoma
by: Ernesto Rossi, et al.
Published: (2021)